Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent successful statewide roll-out.
Grayson ML, Jarvie LJ, Martin R, Johnson PD, Jodoin ME, McMullan C, Gregory RH, Bellis K, Cunnington K, Wilson FL, Quin D, Kelly AM; Hand Hygiene Study Group and Hand Hygiene Statewide Roll-out Group, Victorian Quality Council. Grayson ML, et al. Among authors: mcmullan c. Med J Aust. 2008 Jun 2;188(11):633-40. doi: 10.5694/j.1326-5377.2008.tb01820.x. Med J Aust. 2008. PMID: 18513171 Clinical Trial.
Implementation of patient and public involvement and engagement (PPIE) for the therapies for long COVID in non-hospitalised individuals (TLC) project.
Aiyegbusi OL, McMullan C, Hughes SE, Turner GM, Haroon S, Hotham R, Brown K, Alder Y, Agyen L, Buckland L, Camaradou J, Chong A, Jeyes F, Matthews KL, Moore P, Ormerod J, Price G, Saint-Cricq M, Stanton D, Walker A, Calvert MJ. Aiyegbusi OL, et al. Among authors: mcmullan c. Res Involv Engagem. 2024 Nov 9;10(1):120. doi: 10.1186/s40900-024-00654-3. Res Involv Engagem. 2024. PMID: 39516880 Free PMC article.
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK).
Garrett A, Allen S, Durkie M, Burghel GJ, Robinson R, Callaway A, Field J, Frugtniet B, Palmer-Smith S, Grant J, Pagan J, McDevitt T, Rowlands CF, McVeigh T, Hanson H, Turnbull C; CanVIG-UK. Garrett A, et al. Genet Med. 2024 Oct 24;27(2):101305. doi: 10.1016/j.gim.2024.101305. Online ahead of print. Genet Med. 2024. PMID: 39489894 Free article.
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial.
Reddy YNV, Butler J, Anstrom KJ, Blaustein RO, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor C, Patel M, Ponikowski P, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F. Reddy YNV, et al. Among authors: mcmullan cj. Eur J Heart Fail. 2024 Oct 30. doi: 10.1002/ejhf.3501. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39473305
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials.
Aiyegbusi OL, Cruz Rivera S, Kamudoni P, Anderson N, Collis P, Denniston AK, Harding R, Hughes SE, Khunti K, Kotecha D, Krumholz H, Liu X, McMullan C, Molony-Oates B, Monteiro J, Myles P, Rantell KR, Soltys K, Verdi R, Wilson R, Calvert MJ. Aiyegbusi OL, et al. Among authors: mcmullan c. Nat Med. 2024 Nov;30(11):3075-3084. doi: 10.1038/s41591-024-03323-w. Epub 2024 Oct 29. Nat Med. 2024. PMID: 39472759 Review.
Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial.
Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, Ponikowski P, Voors A, Corda S, McMullan C, O'Connor CM, Anstrom KJ, Armstrong PW; VICTORIA Study Group. Kittipibul V, et al. Among authors: mcmullan c. ESC Heart Fail. 2024 Oct 22. doi: 10.1002/ehf2.15134. Online ahead of print. ESC Heart Fail. 2024. PMID: 39434631 Free article.
Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignancies.
Khatsuria F, McMullan C, Aiyegbusi OL, Shaw KL, Iqbal R, Kinsella F, Wilson K, Pyatt L, Lewis M, Wheldon SMR, Burns D, Chakraverty R, Calvert M, Hughes SE. Khatsuria F, et al. Among authors: mcmullan c. Lancet Oncol. 2024 Oct;25(10):e476-e488. doi: 10.1016/S1470-2045(24)00256-0. Lancet Oncol. 2024. PMID: 39362259 Review.
Key considerations for digital decentralised clinical trials from a feasibility study assessing pacing interventions for long COVID.
McMullan C, Haroon S, Turner G, Aiyegbusi OL, Subramanian A, Hughes SE, Flanagan S, Nirantharakumar K, Davies EH, Frost C, Jackson L, Guan N, Alder Y, Chong A, Buckland L, Jeyes F, Stanton D, Calvert M. McMullan C, et al. Sci Rep. 2024 Sep 27;14(1):22083. doi: 10.1038/s41598-024-61827-4. Sci Rep. 2024. PMID: 39333196 Free PMC article.
131 results